CHI · C · 16 seasons
| SEASON | TEAM | GP | MIN | FG | FG% | 3PT | 3P% | FT | FT% | OR | DR | REB | AST | BLK | STL | PF | TO | PTS |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2011-12 | PHI | 51 | 15.9 | 2.6-5.7 | 45.0 | 0.1-0.2 | 37.5 | 0.4-0.7 | 52.9 | 1.7 | 3.1 | 4.8 | 0.6 | 0.7 | 0.4 | 2.2 | 0.6 | 5.5 |
| 2012-13 | ORL | 77 | 33.2 | 6.0-11.5 | 51.9 | 0.0-0.0 | 0.0 | 1.1-1.6 | 68.3 | 3.5 | 8.4 | 11.9 | 1.9 | 1.0 | 0.8 | 2.8 | 1.8 | 13.1 |
| 2013-14 | ORL | 57 | 31.8 | 6.2-12.2 | 50.7 | 0.0-0.0 | - | 1.8-2.4 | 76.6 | 3.2 | 7.7 | 11.0 | 1.8 | 0.8 | 1.1 | 3.0 | 2.0 | 14.2 |
| 2014-15 | ORL | 74 | 34.2 | 8.5-16.3 | 52.3 | 0.0-0.1 | 33.3 | 2.2-2.9 | 75.2 | 3.2 | 7.7 | 10.9 | 2.0 | 0.7 | 0.7 | 3.0 | 2.0 | 19.3 |
| 2015-16 | ORL | 65 | 31.3 | 8.2-16.1 | 51.0 | 0.0-0.1 | 22.2 | 1.7-2.3 | 75.3 | 2.7 | 6.2 | 8.9 | 2.8 | 1.1 | 0.8 | 2.7 | 1.9 | 18.2 |
| 2016-17 | ORL | 75 | 28.8 | 6.4-13.7 | 46.8 | 0.3-1.0 | 30.7 | 1.4-2.1 | 66.9 | 2.3 | 8.0 | 10.4 | 2.8 | 1.0 | 1.0 | 2.4 | 1.6 | 14.6 |
| 2017-18 | ORL | 57 | 29.5 | 7.0-14.7 | 47.5 | 1.1-3.6 | 31.4 | 1.4-1.6 | 81.9 | 1.8 | 7.4 | 9.2 | 3.4 | 1.1 | 1.0 | 2.5 | 1.9 | 16.5 |
| 2018-19 | ORL | 80 | 31.4 | 8.8-16.9 | 51.8 | 1.1-2.9 | 36.4 | 2.2-2.8 | 78.9 | 2.8 | 9.2 | 12.0 | 3.8 | 1.1 | 1.0 | 2.0 | 2.0 | 20.8 |
| 2019-20 | ORL | 62 | 32.2 | 8.0-16.7 | 47.7 | 1.6-4.7 | 33.9 | 2.1-2.7 | 78.4 | 2.3 | 8.6 | 10.9 | 3.6 | 0.8 | 0.9 | 2.2 | 1.4 | 19.6 |
| 2020-21 | CHI | 70 | 33.5 | 9.5-19.9 | 47.7 | 2.5-6.3 | 40.0 | 1.9-2.2 | 84.0 | 2.1 | 9.6 | 11.7 | 3.8 | 0.7 | 0.9 | 2.0 | 1.8 | 23.4 |
| 2021-22 | CHI | 73 | 33.1 | 7.5-15.8 | 47.3 | 1.4-4.5 | 31.4 | 1.3-1.7 | 76.0 | 1.9 | 9.1 | 11.0 | 3.2 | 1.0 | 1.0 | 2.5 | 1.9 | 17.6 |
| 2022-23 | CHI | 82 | 33.5 | 7.3-14.0 | 52.0 | 1.5-4.2 | 34.9 | 1.6-1.9 | 83.5 | 1.9 | 9.1 | 11.0 | 3.2 | 0.7 | 0.7 | 2.2 | 1.7 | 17.6 |
| 2023-24 | CHI | 76 | 34.3 | 7.7-15.9 | 48.4 | 1.2-4.1 | 29.4 | 1.4-1.7 | 82.2 | 2.8 | 7.8 | 10.5 | 3.3 | 0.8 | 0.7 | 2.5 | 1.6 | 18.0 |
| 2024-25 | CHI | 73 | 31.2 | 7.5-14.2 | 53.0 | 1.8-4.4 | 40.2 | 1.6-2.0 | 80.5 | 2.4 | 7.6 | 10.1 | 3.5 | 0.7 | 0.8 | 2.2 | 1.6 | 18.5 |
| 2025-26 | BOS | 64 | 28.4 | 6.2-12.5 | 49.3 | 1.6-4.2 | 36.9 | 1.2-1.5 | 82.8 | 2.0 | 6.4 | 8.4 | 3.3 | 0.6 | 0.6 | 2.0 | 1.3 | 15.1 |
| 2026-27 | ORL | 9 | 8.5 | 1.0-2.7 | 37.5 | 0.3-1.4 | 23.1 | 0.1-0.2 | 50.0 | 0.7 | 1.8 | 2.4 | 1.2 | 0.6 | 0.0 | 0.7 | 0.3 | 2.4 |
| Career | 1045 | 31.0 | 7.2-14.5 | 49.7 | 1.0-2.7 | 35.0 | 1.6-2.0 | 77.3 | 2.5 | 7.8 | 10.3 | 2.9 | 0.9 | 0.8 | 2.4 | 1.7 | 16.9 |
Games started is not in our data, so it is not a column here. Everything else is every regular season game he played.
What those averages were worth against the players around him that year. A season is its own league, so these do not add up across rows.
| SEASON | TEAM | FG% | FT% | 3PM | PTS | REB | AST | STL | BLK | TO | RANK |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2011-12 | PHI | +0.12 | -0.52 | -0.77 | -0.43 | +0.54 | -0.64 | -0.63 | +0.53 | +0.72 | 263 of 478 |
| 2012-13 | ORL | +1.86 | -0.39 | -0.87 | +0.93 | +3.32 | +0.03 | +0.34 | +1.31 | -0.86 | 40 of 469 |
| 2013-14 | ORL | +1.68 | +0.17 | -0.91 | +1.05 | +3.02 | +0.02 | +0.96 | +1.00 | -0.98 | 41 of 482 |
| 2014-15 | ORL | +3.05 | +0.10 | -0.93 | +2.03 | +3.06 | +0.10 | +0.19 | +0.76 | -1.11 | 25 of 492 |
| 2015-16 | ORL | +2.30 | +0.03 | -0.92 | +1.74 | +2.18 | +0.53 | +0.37 | +1.49 | -0.96 | 31 of 476 |
| 2016-17 | ORL | +0.54 | -0.79 | -0.61 | +1.02 | +2.81 | +0.54 | +0.95 | +1.44 | -0.59 | 54 of 486 |
| 2017-18 | ORL | +0.75 | +0.40 | +0.39 | +1.40 | +2.40 | +0.89 | +0.84 | +1.86 | -1.02 | 30 of 540 |
| 2018-19 | ORL | +2.25 | +0.40 | +0.22 | +2.00 | +3.31 | +1.08 | +0.96 | +1.79 | -1.17 | 13 of 530 |
| 2019-20 | ORL | +0.78 | +0.19 | +0.75 | +1.71 | +2.91 | +0.94 | +0.63 | +0.88 | -0.36 | 24 of 529 |
| 2020-21 | CHI | +0.70 | +0.62 | +1.67 | +2.23 | +3.36 | +1.00 | +0.80 | +0.67 | -0.84 | 12 of 540 |
| 2021-22 | CHI | +0.64 | -0.05 | +0.59 | +1.49 | +3.15 | +0.75 | +0.85 | +1.61 | -1.03 | 32 of 605 |
| 2022-23 | CHI | +1.32 | +0.45 | +0.56 | +1.25 | +3.18 | +0.60 | +0.31 | +0.82 | -0.72 | 28 of 539 |
| 2023-24 | CHI | +0.56 | +0.37 | +0.31 | +1.42 | +2.95 | +0.72 | +0.17 | +0.95 | -0.75 | 52 of 572 |
| 2024-25 | CHI | +1.90 | +0.30 | +0.80 | +1.46 | +2.67 | +0.78 | +0.40 | +0.77 | -0.65 | 23 of 569 |
| 2025-26 | BOS | +0.67 | +0.32 | +0.59 | +0.93 | +2.05 | +0.67 | -0.21 | +0.63 | -0.26 | 59 of 582 |
| 2026-27 | ORL | -0.34 | -0.20 | -0.68 | -0.89 | -0.40 | -0.41 | -1.17 | +0.34 | +0.86 | 329 of 461 |